Electronic Triggers: Messaging After A1C EHR Alert

Status Completed

Clinical Trial Summary

Studying subjects with HbA1C tests >10 and no follow-up test within 6 months and appointments scheduled in the next 60 days from data run date. Subjects who receive intervention message may be more likely to follow up with their provider to schedule a follow up HbA1C test.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hemoglobins

Clinical Trial Details

NCT number	NCT04869319
Study type	Observational
Source	NYU Langone Health
Contact
Status	Completed
Phase
Start date	July 13, 2020
Completion date	March 28, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03816514` - Noninvasive Hemoglobin Monitoring for Maintaining Hemoglobin Concentration Within the Target Range	N/A
Completed	`NCT02722759` - Haemoglobin Measurement for Babies	N/A
Completed	`NCT01529502` - Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This Setting	Phase 2
Terminated	`NCT00228995` - A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia	Phase 2
Terminated	`NCT00210795` - A Phase II Study to Assess Changes in Physical Function in Elderly Patients With Chronic Anemia	Phase 2
Recruiting	`NCT04189250` - Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol	N/A
Completed	`NCT02876627` - Effect Aerobic Training on Women With Breast Cancer After Chemotherapy	Phase 1
Completed	`NCT02655107` - Non-invasive Measurement of Hemoglobin in Infants and Neonates	N/A
Terminated	`NCT00246597` - A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer	Phase 3
Completed	`NCT05506748` - Association Between Preoperative HALP and Immediate Postoperative Outcomes